These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 9109438

  • 1. Roles of interferon-gamma and interleukin-4 in murine lupus.
    Peng SL, Moslehi J, Craft J.
    J Clin Invest; 1997 Apr 15; 99(8):1936-46. PubMed ID: 9109438
    [Abstract] [Full Text] [Related]

  • 2. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S.
    J Clin Invest; 1996 Apr 01; 97(7):1597-604. PubMed ID: 8601623
    [Abstract] [Full Text] [Related]

  • 3. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E, Lenda DM, Kelley VR.
    J Immunol; 2003 Apr 01; 170(7):3915-25. PubMed ID: 12646661
    [Abstract] [Full Text] [Related]

  • 4. IL-10 regulates murine lupus.
    Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, McNiff J, Madaio MP, Craft J.
    J Immunol; 2002 Aug 15; 169(4):2148-55. PubMed ID: 12165544
    [Abstract] [Full Text] [Related]

  • 5. IgG1 and IgG2a production by autoimmune B cells treated in vitro with IL-4 and IFN-gamma.
    Klinman DM.
    J Immunol; 1990 Apr 01; 144(7):2529-34. PubMed ID: 2108205
    [Abstract] [Full Text] [Related]

  • 6. IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease.
    Bossù P, Neumann D, Del Giudice E, Ciaramella A, Gloaguen I, Fantuzzi G, Dinarello CA, Di Carlo E, Musiani P, Meroni PL, Caselli G, Ruggiero P, Boraschi D.
    Proc Natl Acad Sci U S A; 2003 Nov 25; 100(24):14181-6. PubMed ID: 14615579
    [Abstract] [Full Text] [Related]

  • 7. T helper cell subsets in the pathogenesis of systemic lupus erythematosus.
    Reininger L, Santiago ML, Takahashi S, Fossati L, Izui S.
    Ann Med Interne (Paris); 1996 Nov 25; 147(7):467-71. PubMed ID: 9092356
    [Abstract] [Full Text] [Related]

  • 8. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T, Yoshimoto T, Tsubura A, Matsuzawa A.
    Cell Immunol; 2001 Jun 15; 210(2):77-86. PubMed ID: 11520074
    [Abstract] [Full Text] [Related]

  • 9. Type I IFN protects against murine lupus.
    Hron JD, Peng SL.
    J Immunol; 2004 Aug 01; 173(3):2134-42. PubMed ID: 15265950
    [Abstract] [Full Text] [Related]

  • 10. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice.
    Balomenos D, Rumold R, Theofilopoulos AN.
    J Clin Invest; 1998 Jan 15; 101(2):364-71. PubMed ID: 9435308
    [Abstract] [Full Text] [Related]

  • 11. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice.
    Nicoletti F, Di Marco R, Zaccone P, Xiang M, Magro G, Grasso S, Morrone S, Santoni A, Shoenfeld Y, Garotta G, Meroni P.
    Eur J Immunol; 2000 Feb 15; 30(2):438-47. PubMed ID: 10671199
    [Abstract] [Full Text] [Related]

  • 12. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A.
    J Rheumatol; 2010 Jan 15; 37(1):60-70. PubMed ID: 19955044
    [Abstract] [Full Text] [Related]

  • 13. CD4(+)B220(+)TCRγδ(+) T cells produce IL-17 in lupus-prone MRL/lpr mice.
    Qiu F, Li T, Zhang K, Wan J, Qi X.
    Int Immunopharmacol; 2016 Sep 15; 38():31-9. PubMed ID: 27235595
    [Abstract] [Full Text] [Related]

  • 14. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A, Tesch G, Kinoshita K, Maron R, Weiner HL, Kelley VR.
    J Immunol; 1999 Dec 15; 163(12):6884-91. PubMed ID: 10586090
    [Abstract] [Full Text] [Related]

  • 15. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
    Pan Q, Xiao H, Shi L, He Y, Cai J, Wu J, Li A, Ye L, Yang C, Liu HF.
    Front Immunol; 2020 Dec 15; 11():1047. PubMed ID: 32625200
    [Abstract] [Full Text] [Related]

  • 16. Regulation of T cell-dependent autoantibody production by a gammadelta T cell line derived from lupus-prone mice.
    Fujii T, Okada M, Craft J.
    Cell Immunol; 2002 Dec 15; 217(1-2):23-35. PubMed ID: 12425998
    [Abstract] [Full Text] [Related]

  • 17. Increased activation and altered ratio of interferon-gamma: interleukin-4 secreting cells in MRL-lpr/lpr mice.
    Shirai A, Conover J, Klinman DM.
    Autoimmunity; 1995 Dec 15; 21(2):107-16. PubMed ID: 8679898
    [Abstract] [Full Text] [Related]

  • 18. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR.
    J Immunol; 1998 Jul 01; 161(1):494-503. PubMed ID: 9647261
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse.
    Mishra N, Reilly CM, Brown DR, Ruiz P, Gilkeson GS.
    J Clin Invest; 2003 Feb 01; 111(4):539-52. PubMed ID: 12588892
    [Abstract] [Full Text] [Related]

  • 20. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
    Tada Y, Kondo S, Aoki S, Koarada S, Inoue H, Suematsu R, Ohta A, Mak TW, Nagasawa K.
    Arthritis Rheum; 2011 Mar 01; 63(3):738-48. PubMed ID: 21305501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.